- Functional cure of chronic hepatitis B encounters resmetirom
-
Yang NB, Seto WK, Zheng MH
- KMID: 2557403
- Clin Mol Hepatol.
- 2024 Jul;30(3):580-581.
- doi: 10.3350/cmh.2024.0301
-
- CITED
-
- Close
- SHARE
-
- Close
- Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
-
Liu WY, Zhang X, Li G, Tang LJ, Zhu PW, Rios RS, Zheng KI, Ma HL, Wang XD, Pan Q, de Knegt RJ, Valenti L, Ghanbari M, Zheng MH
- KMID: 2528248
- Clin Mol Hepatol.
- 2022 Apr;28(2):183-195.
- doi: 10.3350/cmh.2021.0301
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic dysfunction. Among the multiple factors, genetic variation acts as important modifiers. Klotho, an enzyme encoded by the klotho (KL)... -
- CITED
-
- Close
- SHARE
-
- Close
- MAFLD: How is it different from NAFLD?
-
Gofton C, Upendran Y, Zheng MH, George J
- KMID: 2539787
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S17-S31.
- doi: 10.3350/cmh.2022.0367
“Metabolic dysfunction-associated fatty liver disease (MAFLD)” is the term suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation. The name change from nonalcoholic fatty liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
-
Zhang XL, Wang TY, Targher G, Byrne CD, Zheng MH
- KMID: 2530178
- Diabetes Metab J.
- 2022 May;46(3):391-401.
- doi: 10.4093/dmj.2022.0048
Non-alcoholic fatty liver disease occurring in non-obese subjects (the so-called non-obese NAFLD) is a highly prevalent but neglected liver condition, which is closely associated with metabolic disorders and suboptimal lifestyles.... -
- CITED
-
- Close
- SHARE
-
- Close
- Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
-
Miao L, Xu J, Targher G, Byrne CD, Zheng MH
- KMID: 2534339
- Clin Mol Hepatol.
- 2022 Oct;28(4):725-738.
- doi: 10.3350/cmh.2022.0015
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease with a global prevalence of about 55% in people with type 2 diabetes mellitus (T2DM). T2DM, obesity... -
- CITED
-
- Close
- SHARE
-
- Close
- Temporal Changes of Clomiphene on Testosterone Levels and Semen Parameters in Subfertile Men
-
Jiang T, Sigalos JT, Osadchiy V, Santamaria A, Zheng MH, Modiri N, Regets KV, Mills JN, Eleswarapu SV
- KMID: 2537129
- World J Mens Health.
- 2023 Jan;41(1):198-203.
- doi: 10.5534/wjmh.220010
Purpose: Clomiphene citrate (CC) is prescribed off-label in men to improve testosterone and sperm parameters, but the duration of treatment needed to reach maximal benefit remains unclear. Our objective was... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
-
Xu G, Wang YM, Ying MM, Chen SD, Li ZR, Ma HL, Zheng MH, Wu J, Ding C
- KMID: 2514774
- Clin Mol Hepatol.
- 2021 Apr;27(2):329-345.
- doi: 10.3350/cmh.2020.0261
Background/Aims: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of... -
- CITED
-
- Close
- SHARE
-
- Close
